2B70.DE vs. LYP6.DE
2B70.DE (iShares Nasdaq US Biotechnology UCITS ETF) and LYP6.DE (Amundi Core STOXX Europe 600 (DR) UCITS ETF Acc) are both exchange-traded funds - 2B70.DE is a Health & Biotech Equities fund tracking the Nasdaq Biotechnology, while LYP6.DE is a Europe Equities fund tracking the STOXX® Europe 600. Both are passively managed. Over the past 5 years, 2B70.DE returned 4.63%/yr vs 9.81%/yr for LYP6.DE. At a 0.50 correlation, their price movements are largely independent. 2B70.DE charges 0.35%/yr vs 0.07%/yr for LYP6.DE.
Performance
2B70.DE vs. LYP6.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, 2B70.DE achieves a 5.03% return, which is significantly lower than LYP6.DE's 8.98% return.
2B70.DE
- 1D
- 0.94%
- 1M
- 2.60%
- YTD
- 5.03%
- 6M
- 6.22%
- 1Y
- 38.82%
- 3Y*
- 10.15%
- 5Y*
- 4.63%
- 10Y*
- —
LYP6.DE
- 1D
- 1.90%
- 1M
- 4.91%
- YTD
- 8.98%
- 6M
- 11.60%
- 1Y
- 19.51%
- 3Y*
- 14.24%
- 5Y*
- 9.81%
- 10Y*
- 10.02%
2B70.DE vs. LYP6.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF | 5.03% | 18.57% | 4.69% | 2.49% | -6.33% | 7.72% | 14.37% | 30.21% | -7.20% | -19.24% |
LYP6.DE Amundi Core STOXX Europe 600 (DR) UCITS ETF Acc | 8.98% | 20.82% | 8.25% | 15.97% | -10.40% | 24.81% | -1.72% | 28.59% | -11.28% | 0.00% |
Correlation
The correlation between 2B70.DE and LYP6.DE is 0.46, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.46 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.45 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.45 |
Correlation (All Time) Calculated using the full available price history since Oct 19, 2017 | 0.50 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
2B70.DE vs. LYP6.DE — Risk / Return Rank
2B70.DE
LYP6.DE
2B70.DE vs. LYP6.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and Amundi Core STOXX Europe 600 (DR) UCITS ETF Acc (LYP6.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| 2B70.DE | LYP6.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.59 | ||
| Sortino ratioReturn per unit of downside risk | +0.75 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.26 | +0.07 |
| Calmar ratioReturn relative to maximum drawdown | 6.16 | 1.94 | +4.21 |
| Martin ratioReturn relative to average drawdown | 17.53 | 7.50 | +10.04 |
Loading charts...
Drawdowns
2B70.DE vs. LYP6.DE - Drawdown Comparison
The maximum 2B70.DE drawdown since its inception was -30.92%, smaller than the maximum LYP6.DE drawdown of -35.51%. Use the drawdown chart below to compare losses from any high point for 2B70.DE and LYP6.DE.
Loading charts...
Drawdown Indicators
| 2B70.DE | LYP6.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.92% | -35.51% | +4.59% |
Max Drawdown (1Y)Largest decline over 1 year | -6.28% | -9.45% | +3.17% |
Max Drawdown (3Y)Largest decline over 3 years | -29.42% | -16.26% | -13.16% |
Max Drawdown (5Y)Largest decline over 5 years | -30.92% | -20.71% | -10.21% |
Max Drawdown (10Y)Largest decline over 10 years | — | -35.51% | — |
Current DrawdownCurrent decline from peak | -0.79% | -0.24% | -0.55% |
Average DrawdownAverage peak-to-trough decline | -11.80% | -5.23% | -6.57% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.17% | 2.45% | -0.28% |
Volatility
2B70.DE vs. LYP6.DE - Volatility Comparison
iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) has a higher volatility of 6.57% compared to Amundi Core STOXX Europe 600 (DR) UCITS ETF Acc (LYP6.DE) at 4.31%. This indicates that 2B70.DE's price experiences larger fluctuations and is considered to be riskier than LYP6.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| 2B70.DE | LYP6.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.57% | 4.31% | +2.26% |
Volatility (6M)Calculated over the trailing 6-month period | 14.63% | 10.85% | +3.78% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.40% | 13.06% | +6.34% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.43% | 14.43% | +6.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.35% | 15.56% | +6.79% |
2B70.DE vs. LYP6.DE - Expense Ratio Comparison
2B70.DE has a 0.35% expense ratio, which is higher than LYP6.DE's 0.07% expense ratio.
Dividends
2B70.DE vs. LYP6.DE - Dividend Comparison
Neither 2B70.DE nor LYP6.DE has paid dividends to shareholders.
Frequently Asked Questions
2B70.DE and LYP6.DE have a correlation of 0.46, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, LYP6.DE is cheaper at 0.07% per year. The better choice depends on whether you care most about return, fees, risk, or income.
LYP6.DE is cheaper with a 0.07% expense ratio, compared with 0.35% for 2B70.DE.
2B70.DE is categorized as Health & Biotech Equities, while LYP6.DE is Europe Equities. 2B70.DE tracks Nasdaq Biotechnology, while LYP6.DE tracks STOXX® Europe 600. They also come from different issuers: iShares and Amundi. Their fees differ too: 0.35% for 2B70.DE and 0.07% for LYP6.DE.
Find the right allocation for 2B70.DE and LYP6.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer